Authors


Brett Watson, MD

Latest:

Management of UTUC using a kidney-sparing approach

Advances in endourology have made kidney-sparing treatments a viable treatment option.


Jason M. Hafron, MD, CMO

Latest:

Optimization of Genetic Testing for mCRPC

Jason M. Hafron, MD, CMO, and Oliver Sartor, MD, share their approach for the optimal management of mCRPC through genetic testing.


Joshua Calvert, MD, MPH

Latest:

Robotics in GU oncology: Current status, future directions

The breadth of applications will widen as the number of new platforms grows, according Joshua Calvert, MD, MPH.

© 2024 MJH Life Sciences

All rights reserved.